Stanford Graduate School of Business (USA)
-
Beautycounter
Grousbeck I; Rosenthal SCase SGSB-E456-EEntrepreneurshipThe case profiles Gregg Renfrew, the CEO and founder of Beautycounter, a non-toxic cosmetics company set to launch in January 2013. After developing a personal passion for the non-toxic goods space, Gregg decides in 2010 to launch her own company. She recruits Tim Mitchell, a long-time friend and mentor, as a board member and brand strategy consultant. Tim proves his value at the get go, but a series of inappropriate blowups at the office comb...Starting at €8.20
-
East College Preparatory School
Meehan, W; Luedtke, PCase SGSB-SI13-EBusiness Ethics and Corporate Social Responsibility, EntrepreneurshipEastside College Preparatory School was founded in 1996 to give students in the economically depressed communities of East Palo Alto and Menlo Park a viable option for high school education. This case describes the formation, management, and challenges of Eastside. It focuses on fundraising, performance measurement, faculty recruiting, growth, and managing culture.Starting at €8.20
-
Operation Warp Speed and the COVID-19 Vaccine
Schulman, Kevin; Thiagaraj, AbishekCase SGSB-SM345-EStrategyAs the COVID-19 pandemic shut down businesses and schools in 2020, global health authorities and governments kick-started the quest for a vaccine for the novel coronavirus. This case study details Operation Warp Speed, the $18 billion public-private partnership initiated by the U.S. government to accelerate the research, development, manufacture and distribution of COVID-19 vaccine therapies. The case explores the history of public-private partn...Starting at €8.20
-
The Teladoc and Livongo Merger
Schulman, Kevin; Surendra Jain, Adesh; Naude Bremer Du Plessis, PieterCase SGSB-SM349-EStrategyTeladoc and Livongo had ridden the tailwinds of the COVID-19 pandemic—and a merger between the two would offer a “one-stop-shop” for technology-driven care for patients with acute, chronic, and specialty care needs. The case study describes the regulatory history of telemedicine in the United States, and the licensing barriers that had inhibited virtual doctors’ visits—until the 2020 COVID-19 pandemic forced urgent changes to the ways doctors and...Starting at €8.20